Access cutting-edge heart failure treatment through this clinical trial at a research site in Hammond. Study-provided care at no cost to qualified participants.
Access heart failure specialists in Hammond at no cost
This study follows strict safety protocols and ethical guidelines
All study-related heart failure treatment provided free
This study will evaluate the efficacy, safety, tolerability and pharmacokinetics of JTT-861 administered once daily for 12 weeks in subjects with heart failure with reduced ejection fraction (HFrEF) who are on a stable, guideline-directed medical therapy for heart failure.
Sponsor: Akros Pharma Inc.
Check if you qualify for this heart failure clinical trial in Hammond, IN
If you're searching for heart failure treatment options in Hammond, IN, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Hammond research site is actively enrolling participants for this clinical trial. You'll receive care from experienced heart failure specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.